CJC-1295 and Modified GRF 1-29 are synthetic growth hormone-releasing hormone analogs sharing a core peptide sequence. This comparative review explores how
Read more CJC-1295 vs. Modified GRF 1-29: Comparative Pharmacology and Receptor Kinetics
CJC-1295 and Modified GRF 1-29 are synthetic growth hormone-releasing hormone analogs sharing a core peptide sequence. This comparative review explores how
Read more CJC-1295 vs. Modified GRF 1-29: Comparative Pharmacology and Receptor Kinetics
FOXO4-DRI gained attention as a targeted senolytic peptide, but significant translational hurdles, mechanistic safety questions, and a complete absence of
Read more FOXO4-DRI: Translational Hurdles, Safety Questions, and Human Research Gaps
ARA-290 (cibinetide) is an 11-amino-acid peptide designed to isolate the tissue-protective properties of erythropoietin from its red blood cell-stimulating
Read more ARA-290 vs. Erythropoietin: Tissue Protection Without Erythropoiesis
The GLOW peptide stack combines BPC-157, TB-500, and GHK-Cu in regenerative research models. While individual components demonstrate preclinical actions in
Read more The GLOW Peptide Stack: Preclinical Evidence, Synergy Hypotheses, and Research Limitations
Selank is a synthetic heptapeptide derived from the endogenous immunomodulator tuftsin. This article examines the molecular research behind Selank, focusin
Read more Selank and the Immune System: Tuftsin Biology, Cytokines, and Gene Expression
Delta sleep-inducing peptide (DSIP, emideltide) has been investigated for decades in sleep architecture and stress modulation. This review examines how ear
Read more DSIP: Preclinical vs. Human Evidence in Sleep and Stress Research
Ipamorelin is a synthetic pentapeptide and selective ghrelin receptor agonist. While human pharmacokinetic trials demonstrate selective growth hormone rele
Read more Ipamorelin in Clinical Research: Endocrine Profile, Motility Studies, and Limitations
Oxytocin central delivery is constrained by the blood-brain barrier. Intranasal administration aims to bypass this obstacle via olfactory and trigeminal ne
Read more Oxytocin and the Blood-Brain Barrier: Delivery Mechanisms and Research Limitations
IGF-1 LR3 is an engineered 83-amino-acid growth factor analog. By resisting binding proteins, it provides prolonged activation of the IGF-1 receptor, initi
Read more IGF-1 LR3: Mechanism of Action and Cellular Signaling Pathways